Constitutive expression of peroxisome proliferator-activated receptor α-regulated genes in dwarf mice

Molecular Pharmacology

Volumn 67, Issue 3, 2005, Pages 681-694

  Stauber, Anja J ^a,g   Brown Borg, Holly ^b   Liu, Jie ^c   Waalkes, Michael P ^c   Laughter, Ashley ^a   Staben, Rebecca A ^a   Coley, Jaqueline C ^a,f   Swanson, Cynthia ^a   Voss, Kenneth A ^d   Kopchick, John J ^e   Corton, J Christopher ^a,f  

^a CIIT CENTERS FOR HEALTH RESEARCH   (United States)

^b UNIVERSITY OF NORTH DAKOTA SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^c NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^d AGRICULTURAL RESEARCH SERVICE   (United States)

^e OHIO UNIVERSITY   (United States)

^f ToxicoGenomics   (United States)

^g ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS RECEPTOR; CHAPERONIN; FIBRINOGEN; GENE PRODUCT; GROWTH HORMONE; MESSENGER RNA; PEROXISOME PROLIFERATOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIRINIXIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CARDIOVASCULAR DISEASE; DNA FINGERPRINTING; DRUG EFFECT; DWARFISM; FATTY ACID OXIDATION; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GROWTH HORMONE RELEASE; HETEROZYGOTE; HORMONE RELEASE; LIPID METABOLISM; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; STRESS; UNINDEXED SEQUENCE; WILD TYPE;

ANIMALS; BASE SEQUENCE; DNA PRIMERS; DWARFISM; GENE EXPRESSION REGULATION; MICE; MICE, KNOCKOUT; MICE, MUTANT STRAINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PPAR ALPHA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 20144364633     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.104.007278     Document Type: Article

References (40)

1. Anderson SP, Howroyd P, Liu J, Qian X, Bahnemann R, Swanson C, Kwak MK, Kensler TW, and Corton JC (2004) The transcriptional response to a peroxisome proliferator-activated receptor α agonist includes increased expression of proteome maintenance genes. J Biol Chem 279:52390-52398.
2. Anderson SP, Yoon L, Richard EB, Dunn CS, Cattley RC, and Corton JC (2002) Delayed liver regeneration in peroxisome proliferator-activated receptor-alpha-null mice. Hepatology 36:544-554.
3. Barbier O, Torra IP, Duguay Y, Blanquart C, Fruchart JC, Glineur C, and Staels B (2002) Pleiotropic actions of peroxisome proliferator-activated receptors in lipid metabolism and atherosclerosis. Arterioscler Thromb Vasc Biol 22:717-726.
4. Barger PM, Browning AC, Garner AN, and Kelly DP (2001) p38 mitogen-activated protein kinase activates peroxisome proliferator-activated receptor α: a potential role in the cardiac metabolic stress response. J Biol Chem 276:44495-44501.
5. Bielschowsky F and Bielschowsky M (1961) Carcinogenesis in the pituitary of dwarf mouse. The response to dimethylbenzanthracene applied to the skin. Br J Cancer 15:257-262.
6. Borg KE, Brown-Borg HM, and Bartke A (1995) Assessment of the primary adrenal cortical and pancreatic hormone basal levels in relation to plasma glucose and age in the unstressed Ames dwarf mouse. Proc Soc Exp Biol Med 210:126-133.
7. Brown-Borg HM and Rakoczy SG (2000) Catalase expression in delayed and premature aging mouse models. Exp Gerontol 35:199-212.
8. Bugni JM, Poole TM, and Drinkwater NR (2001) The little mutation suppresses DEN-induced hepatocarcinogenesis in mice and abrogates genetic and hormonal modulation of susceptibility. Carcinogenesis 22:1853-1862.
9. Cattley RC and Popp JA (1989) Differences between the promoting activities of the peroxisome proliferator WY-14,643 and phenobarbital in rat liver. Cancer Res 49:3246-3251.
10. Conway JG, Tomaszewski KE, Olson MJ, Cattley RC, Marsman DS, and Popp JA (1989) Relationship of oxidative damage to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and Wy-14,643. Carcinogenesis 10:513-519.
11. Corton JC, Fan LQ, Brown S, Anderson SP, Bocos C, Cattley RC, Mode A, and Gustafsson JA (1998) Down-regulation of cytochrome P450 2C family members and positive acute-phase response gene expression by peroxisome proliferator chemicals. Mol Pharmacol 54:463-473.
12. Corton JC, Anderson SP, and Stauber A (2000) Central role of peroxisome proliferator-activated receptors in the actions of peroxisome proliferators. Annu Rev Pharmacol Toxicol 40:491-518.
13. Corton JC, Apte U, Anderson SP, Limaye P, Yoon L, Latendresse J, Dunn C, Everitt JI, Voss KA, Swanson C, et al., (2004) Caloric restriction mimetics include agonists of lipid-activated nuclear receptors. J Biol Chem 279:46204-46212.
14. Dozmorov I, Galecki A, Chang Y, Krzesicki R, Vergara M, and Miller RA. Gene expression profile of long-lived snell dwarf mice. J Gerontol A Biol Sci Med Sci 57:B99-B1082.
15. Eisen MB, Spellman PT, Brown PO, and Botstein D (1998) Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 95:14863-14868.
16. Howroyd P, Swanson C, Dunn C, Cattley RC, and Corton JC (2004) Decreased longevity and enhancement of age-dependent lesion in mice lacking the nuclear receptor peroxisome proliferator-activated receptor α (PPARα) Toxicol Pathol, in press.
17. Ikeno Y, Bronson RT, Hubbard GB, Lee S, and Bartke A (2003) Delayed occurrence of fatal neoplastic diseases in Ames dwarf mice: correlation to extended longevity. J Gerontol A Biol Sci Med Sci 58:291-296.
18. Juge-Aubry CE, Hammar E, Siegrist-Kaiser C, Pernin A, Takeshita A, Chin WW, Burger AG, and Meier CA (1999) Regulation of the transcriptional activity of the peroxisome proliferator-activated receptor α by phosphorylation of a ligand-independent trans-activating domain. J Biol Chem 274:10505-10510.
19. Kepler TB, Crosby L, and Morgan KT (2002). Normalization and analysis of DNA microarray data by self-consistency and local regression. Genome Biol 3(7): RESEARCH0037.
20. Klaunig JE, Babich MA, Baetcke KP, Cook JC, Corton JC, David RM, DeLuca JG, Lai DY, McKee RH, Peters JM, et al. (2003) PPARalpha agonist-induced rodent tumors: modes of action and human relevance. Crit Rev Toxicol 33:655-780.
21. Latchman DS (2001) Heat shock proteins and cardiac protection. Cardiovasc Res 51:637-646.
22. Lee SS, Pineau T, Drago J, Lee EJ, Owens JW, Kroetz DL, Fernandez-Salguero PM, Westphal H, and Gonzalez FJ (1995) Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol Cell Biol 15:3012-3022.
23. Liu PC, Huber R, Stow MD, Schlingmann KL, Collier P, Liao B, Link J, Burn TC, Hollis G, Young PR, et al. (2003) Induction of endogenous genes by peroxisome proliferator activated receptor alpha ligands in a human kidney cell line and in vivo. J Steroid Biochem Mol Biol 85:71-79.
24. Marmary Y, Parlow AF, Goldsmith CM, He X, Wellner RB, Satomura K, Kriete MF, Robey PG, Nieman LK, and Baum BJ (1999) Construction and in vivo efficacy of a replication-deficient recombinant adenovirus encoding murine growth hormone. Endocrinology 140:260-265.
25. Mehendale HM (2000) PPAR-alpha: a key to the mechanism of hepatoprotection by clofibrate. Toxicol Sci 57:187-190.
26. Murakami S, Salmon A and Miller RA (2003) Multiplex stress resistance in cells from long-lived dwarf mice. FASEB J 17:1565-1566.
27. Rennels EG, Anigstein DM, and Anigstein L (1965) A cumulative study of the growth of sarcoma 180 in anterior pituitary dwarf mice. Tex Rep Biol Med 23:776-781.
28. Sausen PJ, Lee DC, Rose ML, and Cattley RC (1995) Elevated 8-hydroxydeoxyguanosine in hepatic DNA of rats following exposure to peroxisome proliferators: relationship to mitochondrial alterations. Carcinogenesis 16:1795-1801.
29. Shipley JM and Waxman DJ (2003) Down-regulation of STAT5b transcriptional activity by ligand-activated peroxisome proliferator-activated receptor (PPAR)α and PPARγ. Mol Pharmacol 64:355-364.
30. Sterchele PF, Sun H, Peterson RE, and Vanden Heuvel JP (1996) Regulation of peroxisome proliferator-activated receptor-alpha mRNA in rat liver. Arch Biochem Biophys 326:281-289.
31. Styles JA, Kelly MD, Pritchard NR, and Foster JR (1990) Effects produced by the non-genotoxic hepatocarcinogen methylclofenapate in dwarf mice: peroxisome induction uncoupled from DNA synthesis and nuclearity changes. Carcinogenesis 11:387-391.
32. Sugiyama H, Yamada J, and Suga T (1994) Effects of testosterone, hypophysectomy and growth hormone treatment on clofibrate induction of peroxisomal beta-oxidation in female rat liver. Biochem Pharmacol 47:918-921.
33. Tatar M, Bartke A, and Antebi A (2003) The endocrine regulation of aging by insulin-like signals. Science (Wash DC) 299:1346-1351.
34. Thuillier P, Anchiraico GJ, Nickel KP, Maldve RE, Gimenez-Conti I, Muga SJ, Liu KL, Fischer SM, and Belury MA (2000) Activators of peroxisome proliferator-activated receptor-alpha partially inhibit mouse skin tumor promotion. Mol Carcinog 29:134-142.
35. Tollet-Egnell P, Flores-Morales A, Stahlberg N, Malek RL, Lee N, and Norstedt G (2001) Gene expression profile of the aging process in rat liver: normalizing effects of growth hormone replacement. Mol Endocrinol 15:308-318.
36. Yokota SI, Yanagi H, Yura T, and Kubota H (2000) Cytosolic chaperonin-containing t-complex polypeptide 1 changes the content of a particular subunit species concomitant with substrate binding and folding activities during the cell cycle. Eur J Biochem 267:1658-1664.
37. Zhou Y, Xu BC, Maheshwari HG, He L, Reed M, Lozykowski M, Okada S, Cataldo L, Coschigamo K, Wagner TE, Baumann G and Kopchick JJ (1997) A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse). Proc Natl Acad Sci USA 94:3215-3220.
38. Zhou YC, Davey HW, McLachlan MJ, Xie T, and Waxman DJ (2002) Elevated basal expression of liver peroxisomal beta-oxidation enzymes and CYP4A microsomal fatty acid omega-hydroxylase in STAT5b(-/-) mice: cross-talk in vivo between peroxisome proliferator-activated receptor and signal transducer and activator of transcription signaling pathways. Toxicol Appl Pharmacol 182:1-10.
39. Zhou YC and Waxman DJ (1999a) Cross-talk between janus kinase-signal transducer and activator of transcription (JAK-STAT) and peroxisome proliferator-activated receptor-α (PPARα) signaling pathways. Growth hormone inhibition of pparalpha transcriptional activity mediated by stat5b. J Biol Chem 274:2672-2681.
40. Zhou YC and Waxman DJ (1999b) STAT5b down-regulates peroxisome proliferator-activated receptor α transcription by inhibition of ligand-independent activation function region-1 trans-activation domain. J Biol Chem 274:29874-29882.